Postauthorization safety study of Clottafact® , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.
Vox Sang
; 113(2): 120-127, 2018 Feb.
Article
in En
| MEDLINE
| ID: mdl-29238971
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fibrinogen
/
Coagulants
/
Hemostatics
/
Afibrinogenemia
Type of study:
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Vox Sang
Year:
2018
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido